BACKGROUND In the United States, human papillomavirus (HPV) and Papanicolaou (Pap)
testing (cotesting) for cervical screening in women ages 30 to 65 years is the preferred …

Previously, the screening for detection of cervical cancer was performed by simple
cervicovaginal sample collected by the physician whenever the patient attended the medical …

Background HPV FOCAL is a randomized trial (ISRCTN79347302, registered 20 Apr 2007)
comparing high-risk (hr) HPV testing vs. liquid-based cytology (LBC) for cervical cancer …

Screening for cervical cancer with cytology testing has been very effective in reducing
cervical cancer in the United States. For decades, the approach was an annual Pap test. In …

Introduction Questions have recently been raised about the acceptability of increased
cervical cancer risk projected with the new guideline-recommended rescreening interval of 5 …

LAZCANO-PONCE, Eduardo et al. Prevention and control of neoplasms associated with
HPV in high-risk groups in Mexico City: The Condesa Study. Salud pública Méx [online] …

Background Almost 20% of US women remain at risk for cervical cancer due to their inability
or unwillingness to participate in periodic clinic-based screening. Self-sampling has been …

Background Although both cervical intraepithelial neoplasia (CIN) II and CIN III carry the
potential to progress into cervical cancer, to date, an optimal screening method for CIN2+ …

Introduction Prior screening results in women diagnosed with cervical carcinoma are only
reported in the literature in small numbers. We wish to examine a larger number of prior …

Introduction: Cervical cancer screening programs all over the world are being radically
revised; preventive screening is increasingly based on detecting infection with human …